MetLife (NYSE:MET – Get Free Report) is scheduled to be releasing its earnings data after the market closes on Wednesday, October 30th. Analysts expect MetLife to post earnings of $2.23 per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $2.28 EPS for the quarter, beating the consensus estimate of $2.13 by $0.15. The firm had revenue of $17.82 billion during the quarter, compared to analyst estimates of $18.57 billion. MetLife had a net margin of 4.23% and a return on equity of 21.41%. The business’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.94 EPS. On average, analysts expect MetLife to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.
MetLife Trading Down 0.1 %
MetLife stock opened at $84.77 on Wednesday. The firm has a 50 day moving average of $79.11 and a 200 day moving average of $74.29. The firm has a market capitalization of $60.28 billion, a price-to-earnings ratio of 29.13, a P/E/G ratio of 0.69 and a beta of 1.04. MetLife has a 12-month low of $57.91 and a 12-month high of $86.94. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.56.
MetLife Announces Dividend
Wall Street Analyst Weigh In
Several research firms have weighed in on MET. TD Cowen began coverage on MetLife in a research note on Wednesday, October 9th. They issued a “buy” rating and a $97.00 price target for the company. Bank of America dropped their price target on MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a research note on Thursday, August 1st. Jefferies Financial Group upped their price target on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research note on Friday, September 27th. Wells Fargo & Company upped their price target on MetLife from $86.00 to $92.00 and gave the stock an “overweight” rating in a research note on Thursday, October 10th. Finally, Piper Sandler increased their target price on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $88.46.
Get Our Latest Stock Analysis on MetLife
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- Financial Services Stocks Investing
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- What Is WallStreetBets and What Stocks Are They Targeting?
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.